These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 22344540

  • 21. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
    Naciri Bennani H, Bonzi JY, Noble J, Terrec F, Motte L, Imerzoukene F, Bugnazet M, Giovannini D, Janbon B, Malvezzi P, Rostaing L, Jouve T.
    Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
    [Abstract] [Full Text] [Related]

  • 22. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 23. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Skhiri H, Morelon E, Noel LH, Mamzer-Bruneel MF, Legendre C, Peraldi MN, Kreis H.
    Transpl Int; 2005 Apr; 18(4):458-60. PubMed ID: 15773967
    [Abstract] [Full Text] [Related]

  • 24. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988 Apr; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 25. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS).
    Shiiki H, Nishino T, Uyama H, Kimura T, Nishimoto K, Iwano M, Kanauchi M, Fujii Y, Dohi K.
    Clin Nephrol; 1996 Dec; 46(6):362-8. PubMed ID: 8982551
    [Abstract] [Full Text] [Related]

  • 26. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS, Sorof JM, Brewer ED, Kale AS.
    Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
    [Abstract] [Full Text] [Related]

  • 27. Primum non nocere: Should adults with idiopathic FSGS receive steroids?
    Franceschini N, Hogan SL, Falk RJ.
    Semin Nephrol; 2003 Mar; 23(2):229-33. PubMed ID: 12704583
    [Abstract] [Full Text] [Related]

  • 28. [Primary focal segmental glomerulosclerosis: clinical and morphological prognostic factors].
    Shilov EM, Tareeva IE, Ivanov AA, Lavrova ON, Krasnova TN, Khudova IIu, Miroshnichenko NG, Ratner MIa, Biriukova LS.
    Ter Arkh; 2000 Mar; 72(6):21-5. PubMed ID: 10900643
    [Abstract] [Full Text] [Related]

  • 29. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
    Pokhariyal S, Gulati S, Prasad N, Sharma RK, Singh U, Gupta RK, Mittal S, Mehta B.
    J Nephrol; 2003 Mar; 16(5):691-6. PubMed ID: 14733415
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
    Segarra Medrano A, Vila Presas J, Pou Clavé L, Majó Masferrer J, Camps Doménech J.
    Nefrologia; 2011 Mar; 31(3):286-91. PubMed ID: 21468162
    [Abstract] [Full Text] [Related]

  • 31. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T, Burst V, Teschner S, Benzing T, Kurschat CE.
    Nephron Clin Pract; 2012 Mar; 120(2):c79-85. PubMed ID: 22286071
    [Abstract] [Full Text] [Related]

  • 32. Review on diagnosis and treatment of focal segmental glomerulosclerosis.
    Deegens JK, Steenbergen EJ, Wetzels JF.
    Neth J Med; 2008 Jan; 66(1):3-12. PubMed ID: 18219061
    [Abstract] [Full Text] [Related]

  • 33. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
    Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group.
    J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
    [Abstract] [Full Text] [Related]

  • 34. Rapamycin for focal segmental glomerulosclerosis: a report of 3 cases.
    Tsagalis G, Psimenou E, Iliadis A, Nakopoulou L, Laggouranis A.
    Am J Kidney Dis; 2009 Aug; 54(2):340-4. PubMed ID: 19303679
    [Abstract] [Full Text] [Related]

  • 35. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil in the treatment of steroid-resistant primary focal segmental glomerulosclerosis.
    Tang S, Ho YW, Leung CY, Lai KN.
    J Nephrol; 2005 Aug; 18(4):429-32. PubMed ID: 16245248
    [Abstract] [Full Text] [Related]

  • 37. Rituximab for post-transplant recurrences of FSGS.
    Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M.
    Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
    [Abstract] [Full Text] [Related]

  • 38. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

  • 39. Recurrence of focal segmental glomerulosclerosis after renal transplantation: a case report.
    Akash N.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):91-4. PubMed ID: 17237899
    [Abstract] [Full Text] [Related]

  • 40. Treatment of FSGS in Children.
    Sethna CB, Gipson DS.
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):194-9. PubMed ID: 24602468
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.